doi: 10.1530/EJE-21-0135 79 HindsMHedbckNSvaneMSMllerAMartinussenCJrgensenNBet al
July 2024 Study Links Active Ingredient in Some GLP-1 Drugs to Vision Loss A new study published in the Journal of the American Medical Associations Ophthalmology linked semaglutide drugs to a type of eye strokes called nonarteritic anterior ischemic optic neuropathy (NAION)
The gradual dose-escalation approach used with these medications serves to minimize gastrointestinal side effects while achieving therapeutic goals
These treatments can help support healthy weight goals when combined with nutrition, exercise, and ongoing medical monitoring
Proceedings of the National Academy of Sciences U S A, 113 (32), E4688-4697
Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF